Full Coverage

GSK Cervical CancerCandidate Vaccine Cervarix(R) Demonstrates Long-Term Protection For More Than...

studentbmj.com
01-Apr-2008
        
Story Timeline:  233 days

New data demonstrate that GlaxoSmithKline's (NYSE: GSK) cervical cancer candidate vaccine, CERVARIX provides significant protection for women against the four most common cancer-causing human papillomavirus types for nearly six and a half years, the longe [read full story]                    

Add Comment
Latest article on this story:

AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain...

 genengnews.com 03-Apr-2008
First article on this story:

Cases of Oral Cancer Mount Study May Show Benefits for Men

 redorbit.com 01-Apr-2008
Selected publications with coverage of this story:
redorbit.com medicalnewstoday.com yahoo.com newswise.com pharmiweb.co.uk phgu.org.uk newsvine.com studentbmj.com prnewswire.com thenews.com.pk ivanhoe.com medicalnewsblog.info
RELATED
Found 7 documents:

Cancer screening

thenews.com.pk
03-Apr-2008
        

Early detection, by way of regular screening, is one of the best ways to beat cancer. The American Cancer Society offers these guidelines for c ... ancer screenings: * Women, starting at age 40, should get an annual mammogram to screen for breast cancer. Beginning at age...

AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain...

finanznachrichten.de
03-Apr-2008
        

TUSTIN, Calif., April 3, 2008 /PRNewswire-FirstCall/ - AMDL, Inc. , headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, ... ... TUSTIN, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- AMDL, Inc. , headquartered in Tustin, California, with...

AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain...

prnewswire.com
03-Apr-2008
        

AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries TUSTIN, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Today, AMDL announced that it has entered into an exclusive sublicense (subject to certain terms and...

Sanofi Pasteur MSD welcomes the Netherlands' recommendation for free HPV vaccination of...

pharmiweb.co.uk
02-Apr-2008
        

Pharma Live ... The Netherlands becomes the seventeenth country in Western Europe[*] to recommend HPV vaccination for adolescent girls LYON, France, 1st April 2008 – Sanofi Pasteur MSD fully supports the recommendation of the Dutch Health Council to include human...

Genomic-based diagnostics show their potential

phgu.org.uk
01-Apr-2008
        

An increasing number of studies are taking place with the aim of identifying the genetic basis of common conditions that have a have a major public health impact such as cardiovascular disease, various cancers and obesity. Such studies are expected to increase understanding of disease processes...

News: Genomic-based diagnostics show their potential

phgu.org.uk
01-Apr-2008
        

An increasing number of studies are taking place with the aim of identifying the genetic basis of common conditions that have a have a major public health impact such as cardiovascular disease, various cancers and obesity. Such studies are expected to increase understanding of disease processes...

Gen-Probe Begins U.S. Clinical Study Of Molecular Test For Human Papillomavirus, Which Causes...

medicalnewsblog.info
01-Apr-2008
        

Gen-Probe Incorporated (Nasdaq: GPRO) announced that the Company has begun a pivotal U.S. clinical trial of its investigational APTIMA(R) assay to detect human papillomavirus (HPV), which causes cervical cancer. “Starting this highly complex, multi-center study was an important goal for Gen-Probe...